Print

Avesthagen-CIPLA JV Signs MOU with CosmosID™ for Improving Diagnosis and Management of Tuberculosis  
2/15/2012 6:28:13 AM

BANGALORE, India--(BUSINESS WIRE)--Avesthagen Limited – India’s leading systems biology biotechnology company, has signed a MOU with CosmosID™, a U.S. based company for collaborating to correctly diagnose and therapeutically manage Tuberculosis treatment.